No Data
China Grand Pharmaceutical and Healthcare Holdings Limited (01672) spent approximately 2.3787 million Hong Kong dollars on October 7 to buy back 1.816 million shares.
China Grand Pharmaceutical and Healthcare Holdings Limited (01672) announced that on October 7, 2024, it spent approximately 2.3787 million Hong Kong dollars to repurchase 1...
US Trade Commission Judge Recommends Importation Ban on Ascletis Pharma's Two Liver Drug Candidates
PharmaEssentia (01672): Two candidate drugs have been preliminarily ruled by the US ITC to be prohibited from being imported into the United States. Intends to request a review.
Golden Age Financial News | Goli Pharmaceutical (01672) announces legal proceedings related to the Group's involvement with Viking Therapeutics, Inc. ("Viking", a pharmaceutical company located in the usa). On December 29, 2022, Viking filed a lawsuit with the United States International Trade Commission ("ITC") located in Washington, D.C., seeking to prohibit the importation of candidate drugs ASC41 and ASC43F produced overseas (such as in china) by the company to the usa for clinical development and commercialization. October 4, 2024
China Resources Pharmaceutical Group Limited (01672) received a preliminary ruling from the ITC on the legal litigation involving ASC41 and ASC43F.
Fosun Pharma - B (01672) issued an announcement, the contents of which relate to the group's involvement with Viking Ther...
Express News | Ascletis Pharma Inc - Initial Determination Found Violation in Importation of Co's Drug Candidates Asc41 & Asc43F Into US
Express News | Ascletis Pharma Inc - on Oct 4, Got Initial Determination From US International Trade Commission, Washington D.c.
No Data
No Data
